Mingmei Xiong
South China Agricultural University(CN)Jiangnan University(CN)Guangdong Pharmaceutical University(CN)Wuxi Fourth People's Hospital(CN)Zoucheng People's Hospital(CN)People's Hospital of Bishan District(CN)State Key Laboratory of Respiratory Disease(CN)Guangzhou Eighth People's Hospital(CN)South China University of Technology(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Pulmonary Hypertension Research and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research, Neuroscience of respiration and sleep, Asthma and respiratory diseases, High Altitude and Hypoxia
Most-Cited Works
- → MDM2-Mediated Ubiquitination of Angiotensin-Converting Enzyme 2 Contributes to the Development of Pulmonary Arterial Hypertension(2020)126 cited
- → TRPC6, a therapeutic target for pulmonary hypertension(2021)57 cited
- → A Functional Variant rs6435156C>T in BMPR2 is Associated With Increased Risk of Chronic Obstructive Pulmonary Disease (COPD) in Southern Chinese Population(2016)53 cited
- → Hypoxia‐induced pulmonary hypertension—Utilizing experiments of nature(2020)38 cited
- → Halofuginone, a promising drug for treatment of pulmonary hypertension(2021)34 cited
- → Chronic Hypoxia Decreases Endothelial Connexin 40, Attenuates Endothelium‐Dependent Hyperpolarization–Mediated Relaxation in Small Distal Pulmonary Arteries, and Leads to Pulmonary Hypertension(2020)29 cited